| Assessment Status |
Assessment process complete |
| HTA ID |
- |
| Drug |
Grass pollen allergen extract |
| Brand |
Oralair® |
| Indication |
For the treatment of allergic grass pollen rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms confirmed by a positive cutaneous test and/or a positive titre of the specific IgE to the grass pollen. |
| Rapid review commissioned |
26/09/2011 |
| Rapid review completed |
03/10/2011 |
| Rapid review outcome |
Full Pharmacoeconomic Evaluation not Recommended. |
